MetaCap

Cingulate Inc. Company Profile

NASDAQ: CINGHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.51-0.75 (-14.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cingulate at a glance

Cingulate Inc. (NASDAQ: CING) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Kansas City, KS. Cingulate is led by Dr. Shane J. Schaffer Pharm.D. and employs about 14 people. The company's shares have traded publicly since 2021.

At a market capitalization of $67.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001862150, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Cingulate do?

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Business description based on the company's public filings.

Company information

Legal name
Cingulate Inc.
Ticker
NASDAQ: CING
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Shane J. Schaffer Pharm.D.
Employees
14
Headquarters
1901 West 47th Place, Kansas City, KS, United States
Phone
913 942 2300
IPO year
2021
Market cap
$67.48M
SEC CIK
0001862150
Latest annual report
10-K · Mar 18, 2026

Companies similar to Cingulate

CING peer companies
CompanyPrice% ChgMarket capCompare
MNOVMedicinova Inc1.31+3.15%$67.11Mvs CING
MAIAMAIA Biotechnology Inc.1.11-2.63%$68.54Mvs CING
PLYXPolaryx Therapeutics Inc.1.33-11.92%$66.30Mvs CING
PMVPPMV Pharmaceuticals Inc.0.876-33.13%$66.17Mvs CING
COYACoya Therapeutics Inc.2.95-1.01%$69.20Mvs CING
GOSSGossamer Bio Inc.10.72-4.54%$65.57Mvs CING
ZYBTZhengye Biotechnology Holding Limited Class A1.48-2.63%$70.14Mvs CING
FBIOFortress Biotech Inc.1.90+7.34%$64.11Mvs CING

Related